Table 2 LncRNAs expression level and TKIs treatment resistance in lung cancer

UCA1

AKT/mTOR

N/D

TKIs

Up

NSCLC

[78]

N/I

N/D

Gefitinib

Up

NSCLC

[85]

GAS5

IGR-1R

N/D

Gefitinib

Down

NSCLC

[81]

MIR31HG

EGFR/PI3K/AKT signaling pathway

N/D

Gefitinib

Up

NSCLC

[84]

BC087858

PI3K/AKT, MEK/ERK

N/D

EGFR-TKIs

Up

NSCLC

[82]

N/I

N/D

Gefitinib

Up

NSCLC

[80]

BC200

N/I

N/D

Gefitinib

Up

NSCLC

[80]

HOTAIR

N/I

N/D

Gefitinib

Down

NSCLC

[80]

MALAT1

N/I

N/D

Gefitinib

Down

NSCLC

[80]

ENST00000507437

N/I

N/D

Gefitinib

Up

NSCLC

[80]

ENST00000508827

N/I

N/D

Gefitinib

Up

NSCLC

[80]

NR_026685

N/I

N/D

Gefitinib

Up

NSCLC

[80]

ENST00000381279

N/I

N/D

Gefitinib

Down

NSCLC

[80]

ENST00000418077

N/I

N/D

Gefitinib

Down

NSCLC

[80]

BG188549

N/I

N/D

Gefitinib

Down

NSCLC

[80]

BE244504

N/I

N/D

Gefitinib

Down

NSCLC

[80]

CASC9

N/I

N/D

Gefitinib

Up

NSCLC

[85]

EWAST1 (LINC00277)

N/I

N/D

Gefitinib

Down

NSCLC

[85]

LINC00524

N/I

N/D

Gefitinib

Down

NSCLC

[85]